Health-related quality of life of alcohol use disorder with co-occurring conditions in the US population.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 04 2021
Historique:
received: 01 11 2020
revised: 27 12 2020
accepted: 29 12 2020
pubmed: 9 2 2021
medline: 9 6 2021
entrez: 8 2 2021
Statut: ppublish

Résumé

Alcohol use disorder (AUD) commonly co-occurs with other health conditions or other substance use, complicating our understanding of the health-related quality of life (HRQoL) of AUD. We described the HRQoL of alcohol use disorder in the presence of co-occurring conditions and identified the contribution of each. Secondary analysis of National Epidemiologic Survey on Alcohol and Related Conditions III data, consisting of 36,309 non-institutionalized US adults; descriptive and regression analysis. HRQoL measured via the SF-6D; AUD via the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS-5); physical, mental health, and substance use disorders/conditions as reported or assessed via AUDADIS-5. AUD was independently associated with lower HRQoL for individuals experiencing co-occurring conditions. Compared to no AUD, past year AUD reduced SF-6D score by 0.0304 (SE = 0.0027) and prior-to-past-year AUD reduced SF-6D by 0.0163 (SE = 0.0023). AUD's co-occurring conditions were independently associated with lower HRQoL, beyond the reduction from AUD: any co-occurring physical health condition was associated with a 0.062 point reduction in SF-6D score (SE = 0.0023), any mental health condition with a 0.084 point reduction (SE = 0.0025), and any substance use disorder with a 0.038 point reduction (SE = 0.0023). AUD's association with diminished HRQoL may be explained in large part by the presence of co-occurring conditions among individuals reporting AUD, as these co-occurring conditions are associated with substantial decrements in HRQoL-often eclipsing the magnitude of the decrements associated with AUD alone. Alcohol use interventions endeavoring to improve HRQoL should consider the entirety of an individual to design patient-centered care.

Sections du résumé

BACKGROUND
Alcohol use disorder (AUD) commonly co-occurs with other health conditions or other substance use, complicating our understanding of the health-related quality of life (HRQoL) of AUD. We described the HRQoL of alcohol use disorder in the presence of co-occurring conditions and identified the contribution of each.
METHODS
Secondary analysis of National Epidemiologic Survey on Alcohol and Related Conditions III data, consisting of 36,309 non-institutionalized US adults; descriptive and regression analysis. HRQoL measured via the SF-6D; AUD via the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS-5); physical, mental health, and substance use disorders/conditions as reported or assessed via AUDADIS-5.
RESULTS
AUD was independently associated with lower HRQoL for individuals experiencing co-occurring conditions. Compared to no AUD, past year AUD reduced SF-6D score by 0.0304 (SE = 0.0027) and prior-to-past-year AUD reduced SF-6D by 0.0163 (SE = 0.0023). AUD's co-occurring conditions were independently associated with lower HRQoL, beyond the reduction from AUD: any co-occurring physical health condition was associated with a 0.062 point reduction in SF-6D score (SE = 0.0023), any mental health condition with a 0.084 point reduction (SE = 0.0025), and any substance use disorder with a 0.038 point reduction (SE = 0.0023).
CONCLUSIONS
AUD's association with diminished HRQoL may be explained in large part by the presence of co-occurring conditions among individuals reporting AUD, as these co-occurring conditions are associated with substantial decrements in HRQoL-often eclipsing the magnitude of the decrements associated with AUD alone. Alcohol use interventions endeavoring to improve HRQoL should consider the entirety of an individual to design patient-centered care.

Identifiants

pubmed: 33556660
pii: S0376-8716(21)00053-3
doi: 10.1016/j.drugalcdep.2021.108558
pmc: PMC8026697
mid: NIHMS1671223
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

108558

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA024423
Pays : United States
Organisme : NIAAA NIH HHS
ID : R15 AA027655
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Med Decis Making. 2008 Jan-Feb;28(1):102-12
pubmed: 18057188
Health Econ. 2004 Sep;13(9):873-84
pubmed: 15362179
Alcohol Clin Exp Res. 2018 Dec;42(12):2453-2465
pubmed: 30395350
J Ment Health Policy Econ. 2009 Mar;12(1):27-31
pubmed: 19346564
Qual Life Res. 2014 Mar;23(2):733-43
pubmed: 24026632
Addiction. 2016 Apr;111(4):675-84
pubmed: 26498740
Med Care. 2004 Sep;42(9):851-9
pubmed: 15319610
Qual Life Res. 2009 Feb;18(1):87-97
pubmed: 19051058
Value Health. 2010 Jun-Jul;13(4):487-94
pubmed: 20230549
Addiction. 2020 Aug 15;:
pubmed: 33448504
Value Health. 2017 Mar;20(3):458-465
pubmed: 28292491
Alcohol Clin Exp Res. 2020 Jan;44(1):36-40
pubmed: 31709568
Med Care. 2007 Dec;45(12):1162-70
pubmed: 18007166
Med Decis Making. 2013 Feb;33(2):139-53
pubmed: 22927696
Am J Prev Med. 2015 Nov;49(5):e73-e79
pubmed: 26477807
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070

Auteurs

Eve Wittenberg (E)

Center for Health Decision Science, Harvard TH Chan School of Public Health, 718 Huntington Avenue, Boston, MA, 02115, USA. Electronic address: ewittenb@hsph.harvard.edu.

Carolina Barbosa (C)

RTI International, 230 West Monroe Street, Suite 2100, Chicago, IL, 60606, USA. Electronic address: cbarbosa@rti.org.

Riley Hein (R)

Bryan School of Business and Economics, University of North Carolina Greensboro, 462 Bryan Building, PO Box 26170, Greensboro NC 27402, USA. Electronic address: rphein@uncg.edu.

Emma Hudson (E)

Bryan School of Business and Economics, University of North Carolina Greensboro, 462 Bryan Building, PO Box 26170, Greensboro NC 27402, USA. Electronic address: echudson@uncg.edu.

Benjamin Thornburg (B)

Bryan School of Business and Economics, University of North Carolina Greensboro, 462 Bryan Building, PO Box 26170, Greensboro NC 27402, USA. Electronic address: bdthorn2@uncg.edu.

Jeremy W Bray (JW)

Bryan School of Business and Economics, University of North Carolina Greensboro, 462 Bryan Building, PO Box 26170, Greensboro NC 27402, USA. Electronic address: jwbray@uncg.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH